GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CrystalGenomics Invites Co Ltd (XKRX:083790) » Definitions » Forward Dividend Yield %

CrystalGenomics Invites Co (XKRX:083790) Forward Dividend Yield % : 0.00% (As of Jun. 24, 2024)


View and export this data going back to 2006. Start your Free Trial

What is CrystalGenomics Invites Co Forward Dividend Yield %?

As of today (2024-06-24), the Forward Annual Dividend Yield of CrystalGenomics Invites Co is 0.00%.

As of today (2024-06-24), the Trailing Annual Dividend Yield of CrystalGenomics Invites Co is 0.00%.

XKRX:083790's Forward Dividend Yield % is not ranked *
in the Biotechnology industry.
Industry Median: 1.63
* Ranked among companies with meaningful Forward Dividend Yield % only.

CrystalGenomics Invites Co's Dividends per Share for the three months ended in Mar. 2024 was ₩0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of CrystalGenomics Invites Co's Forward Dividend Yield %

For the Biotechnology subindustry, CrystalGenomics Invites Co's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CrystalGenomics Invites Co's Forward Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CrystalGenomics Invites Co's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where CrystalGenomics Invites Co's Forward Dividend Yield % falls into.



CrystalGenomics Invites Co Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.


CrystalGenomics Invites Co  (XKRX:083790) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


CrystalGenomics Invites Co Forward Dividend Yield % Related Terms

Thank you for viewing the detailed overview of CrystalGenomics Invites Co's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


CrystalGenomics Invites Co (XKRX:083790) Business Description

Traded in Other Exchanges
N/A
Address
5F, A-dong, Korea Bio Park, 694-1, Sampyeong-dong, Bundang-gu, Seongnam-si, Gyeonggi, KOR, 463-400
CrystalGenomics Invites Co Ltd Formerly CrystalGenomics Inc is one of the leading biopharmaceutical company in Korea. The company is mainly engaged in the research and development and new drug development. It develops innovative new drug development projects such as eradication antibiotics and molecular targeted anticancer drugs. It focuses on arthritic medicines and antibiotics which kill resistant bacteria. It also offers medicines for cancer, obesity, asthma, and diabetes.

CrystalGenomics Invites Co (XKRX:083790) Headlines

No Headlines